Top

Reactions Weekly

Published in:

01-04-2023 | NSCLC | Case report

Nivolumab

Phlegmon: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Cosio T, et al. Pyodermitis during Nivolumab Treatment for Non-Small Cell Lung Cancer: A Case Report and Review of the Literature. [Review]. International Journal of Molecular Sciences 24: No. 5, 26 Feb 2023. Available from: URL: http://doi.org/10.3390/ijms24054580

Title: Nivolumab
Phlegmon: case report
Publication date: 01-04-2023
Publisher: Springer International Publishing
Keywords: NSCLC
Phlegmon
Clarithromycin
NSCLC
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-37757-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Nivolumab

Phlegmon: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Cladribine/cytarabine/idarubicin

Pembrolizumab

Tocilizumab

Cobicistat/elvitegravir/emtricitabine/tenofovir-alafenamide

Antifungals/antineoplastics

Alprostadil/nitrogen